[Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province]
- PMID: 16676594
[Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province]
Abstract
Objective: Based on the distribution of genetic polymorphisms regarding phase I metabolic enzyme cytochrome P450 1A1 (CYP1A1) and phase II metabolic enzymes glutathione S-transferase GSTM1 and GSTT1 genotypes in acute leukemia patients and health controls among general population of Hunan in China, this study was to explore the relationship between these gene polymorphisms and the susceptibility to acute leukemia.
Methods: Using case-control methodology, we studied 204 healthy controls and 232 patients with acute leukemia, of which 112 patients were suffering acute lymphoblastic leukemia (ALL) and 120 with acute non-lymphoblastic leukemia (ANLL). The frequencies of the genotypes were detected by PCR and PCR-RFLP techniques.
Results: The variation frequencies of CYP1A1 gene (Msp I polymorphisms, site 3801T-C variation) in ALL and ANLL groups were 74.1% and 70.8% respectively which were higher than 63.3% appeared in the healthy controls. However, the differences between patients (ALL or ANLL) and healthy controls were not statistically significant (P > 0.05 for both). The null genotype of GSTM1 (GSTM1 -/-) in ALL group was 60.7%, which was not significantly different from the controls (55.4%). However, GSTM1 -/- genotype in ANLL group was 68.3%, significantly different from the controls (P < 0.05). The null genotypes among GSTT1 (GSTT1 -/-) in ALL, ANLL and control group were 50.9%, 55.0% and 49.0% but their differences were not statistically significant (P > 0.05). The incidences of GSTM1 -/- and GSTT1 -/- combined genotype in ALL, ANLL and control group were 33.0%, 40.0% and 27.5%, of which the difference between ANLL group and control group was statistically significant (P < 0.05) and CYP1A1 gene heterozygous mutation type or homozygous mutation type combined with GSTM1 -/- and GSTT1 -/- increased the risk of ANLL (OR value 1.890, 95% CI: 1.084-3.295).
Conclusion: These results indicated that both the variation of CYP1A1 gene or GSTT1 -/- genotype alone might not be associated with the susceptibility of acute leukemia while GSTM1 -/- genotype alone or combined with GSTT1 -/- or the 3801 T-C variation of CYP1A1 gene were correlated with ANLL. These findings suggest that GSTM1 - / - genotype alone or in combination with other defective genotypes might serve as risk factors to the etiology of ANLL.
Similar articles
-
Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.Eur J Cancer Prev. 2008 Jun;17(3):251-8. doi: 10.1097/CEJ.0b013e3282b72093. Eur J Cancer Prev. 2008. PMID: 18414197
-
Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.Am J Hematol. 2003 Jul;73(3):154-60. doi: 10.1002/ajh.10339. Am J Hematol. 2003. PMID: 12827651
-
Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.Am J Hematol. 2006 Mar;81(3):162-70. doi: 10.1002/ajh.20434. Am J Hematol. 2006. PMID: 16493615
-
Association of GSTT1 and GSTM1 polymorphisms with early pregnancy loss in an Indian population and a meta-analysis.Reprod Biomed Online. 2013 Apr;26(4):313-22. doi: 10.1016/j.rbmo.2012.12.004. Epub 2012 Dec 22. Reprod Biomed Online. 2013. PMID: 23433732 Review.
-
[Role of metabolic polymorphisms in lung carcinogenesis].Nihon Koshu Eisei Zasshi. 1999 Apr;46(4):241-9. Nihon Koshu Eisei Zasshi. 1999. PMID: 10491856 Review. Japanese.
Cited by
-
Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.Mol Biol Rep. 2013 Feb;40(2):1307-14. doi: 10.1007/s11033-012-2174-y. Epub 2012 Oct 14. Mol Biol Rep. 2013. PMID: 23065291
-
Association Between the Individual and Combined Effects of the GSTM1 and GSTT1 Polymorphisms and Risk of Leukemia: A Meta-Analysis.Front Genet. 2022 Jul 22;13:898937. doi: 10.3389/fgene.2022.898937. eCollection 2022. Front Genet. 2022. PMID: 35938012 Free PMC article.
-
Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis.Blood Res. 2024 Mar 4;59(1):9. doi: 10.1007/s44313-024-00007-9. Blood Res. 2024. PMID: 38485870 Free PMC article.
-
CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.J Exp Clin Cancer Res. 2012 Jul 30;31(1):62. doi: 10.1186/1756-9966-31-62. J Exp Clin Cancer Res. 2012. PMID: 22846179 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous